Canada Bone Graft And Substitute Market Forecast 2023-2030

Canada Bone Graft And Substitute Market Forecast 2023-2030


KEY FINDINGS

The Canada bone graft and substitute market is expected to project a CAGR of 6.49% during the forecast period, 2023-2030. The aging population in Canada has led to an increased demand for bone graft and substitute procedures, as older individuals are more susceptible to bone-related conditions. Also, advancements in medical technology and materials have led to the development of more effective and biocompatible bone graft and substitute products.

MARKET INSIGHTS

One of the primary growth drivers of the Canada bone graft and substitute market is the growing awareness of the benefits of bone graft and substitute procedures among healthcare professionals and patients. The demand for hip and knee replacements is increasing in Canada, with over 138,500 procedures performed annually, costing an estimated inpatient expense of over $1.4 billion.

According to data from the Canadian Joint Replacement Registry (CJRR), in 2019-2020, Canada saw 63,496 hip replacements and 75,073 knee replacements. Osteoarthritis was the leading diagnosis for primary hip and knee replacement patients, accounting for 72.5% and 99.4%, respectively. Hip and knee replacement surgeries continue to be among the most common medical procedures in Canada, resulting in significant annual healthcare costs. This trend could potentially benefit the bone graft and substitute market, contributing to its growth.

COMPETITIVE INSIGHTS

Some of the eminent companies in the market include Allosource Inc Plc, Bioventus LLC, Baxter International Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges
2.6. Major Market Findings
3. Key Analytics
3.1. Key Market Trends
3.2. Pestle Analysis
3.2.1. Political
3.2.2. Economical
3.2.3. Social
3.2.4. Technological
3.2.5. Legal
3.2.6. Environment
3.3. Porter’s Five Forces Analysis
3.3.1. Buyers Power
3.3.2. Suppliers Power
3.3.3. Substitution
3.3.4. New Entrants
3.3.5. Industry Rivalry
3.4. Opportunity Matrix
3.5. Market Concentration Analysis
3.6. Key Buying Criteria
3.6.1. Cost-effectiveness
3.6.2. Application
3.6.3. Effectiveness
4. Market By Type
4.1. Allografts
4.1.1. Demineralized Bone Matrix
4.1.2. Other Allografts
4.2. Autografts
4.3. Synthetics And Additives
4.3.1. Ceramic
4.3.2. Composite
4.3.3. Polymer
4.3.4. Bone Morphogenetic Proteins
5. Market By Application
5.1. Spinal Fusion
5.1.1. Market Forecast Figure
5.1.2. Segment Analysis
5.2. Long Bone
5.2.1. Market Forecast Figure
5.2.2. Segment Analysis
5.3. Foot And Ankle
5.3.1. Market Forecast Figure
5.3.2. Segment Analysis
5.4. Craniomaxillofacial
5.4.1. Market Forecast Figure
5.4.2. Segment Analysis
5.5. Joint Reconstruction
5.5.1. Market Forecast Figure
5.5.2. Segment Analysis
5.6. Dental
5.6.1. Market Forecast Figure
5.6.2. Segment Analysis
6. Competitive Landscape
6.1. Key Strategic Developments
6.1.1. Mergers & Acquisitions
6.1.2. Product Launches & Developments
6.1.3. Partnerships & Agreements
6.1.4. Business Expansions & Divestitures
6.2. Company Profiles
6.2.1. Arthrex
6.2.1.1. Company Overview
6.2.1.2. Product List
6.2.1.3. Strengths & Challenges
6.2.2. Baxter International Inc
6.2.2.1. Company Overview
6.2.2.2. Product List
6.2.2.3. Strengths & Challenges
6.2.3. Bioventus Llc
6.2.3.1. Company Overview
6.2.3.2. Product List
6.2.3.3. Strengths & Challenges
6.2.4. Depuy Synthes Companies
6.2.4.1. Company Overview
6.2.4.2. Product List
6.2.4.3. Strengths & Challenges
6.2.5. Integra Lifesciences
6.2.5.1. Company Overview
6.2.5.2. Product List
6.2.5.3. Strengths & Challenges
6.2.6. Medtronic Inc
6.2.6.1. Company Overview
6.2.6.2. Product List
6.2.6.3. Strengths & Challenges
6.2.7. Nuvasive Inc
6.2.7.1. Company Overview
6.2.7.2. Product List
6.2.7.3. Strengths & Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings